S. Joseph Sirintrapun

Massachusetts General Hospital — United States

Computer Science · Physical Sciences

35h-index4.0kcitations131works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

AI in cancer detection(24), Renal cell carcinoma treatment(20), Bladder and Urothelial Cancer Treatments(18), Cancer Genomics and Diagnostics(18), Cancer, Lipids, and Metabolism(14)

Publications130 total

ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings
2025Open Access
Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology
JCO Clinical Cancer Informatics·2025
Regulatory aspects of digital pathology
Elsevier eBooks·2024
List of contributors
Elsevier eBooks·2024Open Access
A multicenter study to evaluate the analytical precision by pathologists using the Aperio GT 450 DX
Journal of Pathology Informatics·2024· 1 citedOpen Access
Review for "AI-Based Computational H&E Staining Enables Spatial Transcriptomic Analysis in Classic Hodgkin Lymphoma"
2024
L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma
Modern Pathology·2024· 14 citedOpen Access
Molecular, immunohistochemical and clinical determinants of urothelial carcinoma of the bladder with nested subtype
European Urology·2024
Examining the role of diversity, equity, and inclusion in mitigating workforce burnout in laboratory medicine
American Journal of Clinical Pathology·2023· 10 cited
Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations
Pediatric Blood & Cancer·2023· 5 citedOpen Access
Supplementary Figure 4 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure 1 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Data from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure Legends and Tables from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure 3 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure 2 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure Legends and Tables from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure 4 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Data from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
Supplementary Figure 2 from Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Victor E. Reuter(22), Samson W. Fine(16), Hikmat Al‐Ahmadie(16), Ying‐Bei Chen(15), Anuradha Gopalan(15), Satish K. Tickoo(15), Matthew G. Hanna(9), Meera Hameed(9), David B. Solit(8), Christine England(7), David S. Klimstra(7), Lorraine Corsale(6), Gopa Iyer(6), Judy Sarungbam(6), Evangelos Stamelos(5), Orly Ardon(5), A. Ari Hakimi(5), Bernard H. Bochner(5), Yukako Yagi(4), Peter J. Schüffler(4)